PMAIP1 and non-small cell lung carcinoma: In this study, we demonstrated for the first time that arenobufagin is able to inhibit growth and induce apoptosis in NSCLC cells, by modulation of the Noxa-related pathway, paving the way for this compound to be exploited as a therapeutic agent in the adjunct therapy of NSCLC.